Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.06B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$1.87B |
| 3 |
Apple
AAPL
|
+$1.03B |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$747M |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$730M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$930M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$598M |
| 3 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$524M |
| 4 |
TSMC
TSM
|
+$363M |
| 5 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$357M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.47% |
| 2 | Healthcare | 9.44% |
| 3 | Financials | 9.02% |
| 4 | Consumer Discretionary | 7.88% |
| 5 | Industrials | 5.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABMD
1476
DELISTED
Abiomed Inc
ABMD
| $31.2M | 0.01% |
127,056
+3,230
| +3% | +$872K |
|
1477
WEX
WEX
$6.46B
| $31.2M | 0.01% |
245,806
-34,566
| -12% | -$5.43M |
|
1478
Zebra Technologies
ZBRA
$17.6B
| $31.2M | 0.01% |
118,967
-40,670
| -25% | -$12.6M |
|
|
COOP
1479
DELISTED
Mr. Cooper
COOP
| $31.1M | 0.01% |
767,334
+27,128
| +4% | +$1.15M |
|
1480
Hasbro
HAS
$12.9B
| $31.1M | 0.01% |
460,570
+116,188
| +34% | +$9.18M |
|
1481
PUT
Home Depot
HD
$350B
| $31M | 0.01% |
112,500
+29,300
| +35% | +$8.65M |
|
1482
PUT
Oracle
ORCL
$415B
| $31M | 0.01% |
508,200
-64,000
| -11% | -$4.69M |
|
1483
Myriad Genetics
MYGN
$309M
| $31M | 0.01% |
1,622,321
+320,540
| +25% | +$7.36M |
|
|
CVSA
1484
Covista Inc
CVSA
$4.47B
| $30.9M | 0.01% |
848,112
-74,369
| -8% | -$2.84M |
|
1485
Kinross Gold
KGC
$30.4B
| $30.9M | 0.01% |
8,209,162
+812,263
| +11% | +$2.76M |
|
1486
Loews
L
$23.6B
| $30.9M | 0.01% |
619,316
+82,901
| +15% | +$4.65M |
|
|
WIRE
1487
DELISTED
Encore Wire Corp
WIRE
| $30.9M | 0.01% |
267,109
+1,061
| +0.4% | +$129K |
|
1488
PUT
Paychex
PAYX
$41.9B
| $30.9M | 0.01% |
275,000
-47,600
| -15% | -$5.9M |
|
1489
Okta
OKTA
$25.8B
| $30.8M | 0.01% |
542,378
-416,202
| -43% | -$35.8M |
|
|
RVNC
1490
DELISTED
Revance Therapeutics, Inc.
RVNC
| $30.8M | 0.01% |
1,139,808
+310,883
| +38% | +$6.31M |
|
1491
FB Financial Corp
FBK
$3.1B
| $30.8M | 0.01% |
805,035
+32,940
| +4% | +$1.35M |
|
1492
PUT
CrowdStrike
CRWD
$217B
| $30.8M | 0.01% |
746,400
-154,800
| -17% | -$7.08M |
|
1493
CALL
Teva Pharmaceuticals
TEVA
$40.6B
| $30.7M | 0.01% |
3,809,500
-628,700
| -14% | -$5.56M |
|
1494
Floor & Decor
FND
$6.53B
| $30.7M | 0.01% |
437,125
+31,489
| +8% | +$2.53M |
|
1495
Commerce Bancshares
CBSH
$8.63B
| $30.7M | 0.01% |
564,226
+62,061
| +12% | +$3.54M |
|
|
VIVO
1496
DELISTED
Meridian Bioscience Inc
VIVO
| $30.7M | 0.01% |
973,634
+745,570
| +327% | +$24.1M |
|
|
ACH
1497
Accendra Health
ACH
$236M
| $30.7M | 0.01% |
1,273,719
-43,439
| -3% | -$1.34M |
|
1498
State Street SPDR Dow Jones International Real Estate ETF
RWX
$270M
| $30.4M | 0.01% |
1,262,290
-64,883
| -5% | -$1.81M |
|
1499
Leggett & Platt
LEG
$1.42B
| $30.3M | 0.01% |
913,114
+34,875
| +4% | +$1.33M |
|
1500
Celanese
CE
$4.61B
| $30.3M | 0.01% |
335,760
+56,518
| +20% | +$6.21M |
|
Similar funds
Goldman Sachs's Q3 2022 Portfolio in Review
As of Q3 2022, Goldman Sachs held 6,885 positions worth $396B, down 1.1% from $400B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Goldman Sachs deployed $17.3B of net new capital in Q3 2022, opening 459 new positions and adding to 2,707 existing holdings. Its largest new stake was Schwab US TIPS ETF: 8,348,958 shares worth $216M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $930M trimmed.
- Goldman Sachs's largest Q3 2022 buy was Schwab US TIPS ETF: 8,348,958 shares worth $216M.
- Goldman Sachs added most to Visa in Q3 2022, an estimated $2.06B increase.
- Goldman Sachs's biggest Q3 2022 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $930M.
- Goldman Sachs fully exited Mandiant, Inc. Common Stock in Q3 2022, selling an estimated $236M.
- Goldman Sachs's ten largest holdings make up 18% of its $396B portfolio in Q3 2022.
- Goldman Sachs opened 459 new positions and closed 646 in Q3 2022.
- Goldman Sachs's portfolio value fell 1.1% quarter-over-quarter to $396B.
Based on Goldman Sachs's 13F filing for Q3 2022, filed 14 Nov 2022.